bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

12,492 Articles (9,715 medRxiv, 2,777 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Human Pre-Implantation Embryos Are Permissive to SARS-CoV-2 Entry
Montano, M., Victor, A. R., Griffin, D. K., Duong, T., Bolduc, N., Farmer, A., Garg, V., Hadjantonakis, A.-K., Barnes, F. L., Zouves, C. G., Greene, W. C., Viotti, M.
10.1101/2021.01.21.427501 — Posted: 2021-01-21
Survey of peridomestic mammal susceptibility to SARS-CoV-2 infection
Bosco-Lauth, A., Root, J. J., Porter, S., Walker, A., Guilbert, L., Hawvermale, D., Pepper, A., Maison, R., Hartwig, A., Gordy, P., Bielefeldt-Ohmann, H., Bowen, R. A.
10.1101/2021.01.21.427629 — Posted: 2021-01-21
Personalized Virus Load Curves of SARS-CoV-2 Infection
Hillen, T., Contreras, C., Newby, J.
10.1101/2021.01.21.427676 — Posted: 2021-01-21
Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning
Lopez-Rincon, A., Perez-Romero, C., Tonda, A., Mendoza-Maldonado, L., Claassen, E., Garssen, J., Kraneveld, A. D.
10.1101/2021.01.20.427043 — Posted: 2021-01-21
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
Choi, R., Zhou, M., Shek, R., Wilson, J. W., Tillery, L., Craig, J. K., Salukhe, I. A., Hickson, S. E., Kumar, N., James, R. M., Buchko, G. W., Wu, R., Huff, S., Nguyen, T.-T., Hurst, B. L., Cherry, S., Barrett, L. K., Van Voorhis, W. C.
10.1101/2021.01.21.427657 — Posted: 2021-01-21
In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response
Schaller, M. A., Sharma, Y., Dupee, Z., Nguyen, D. T., Uruena, J. M., Smolcheck, R. A., Loeb, J. C., Machuca, T. N., Lednicky, J. A., Odde, D., Campbell, R. F., Sawyer, W. G., Mehrad, B.
10.1101/2021.01.20.427541 — Posted: 2021-01-21
Evolving Insights from SARS-CoV-2 Genome from 200K COVID-19 Patients
Desai, S. S., Rane, A., Joshi, A., Dutt, A.
10.1101/2021.01.21.427574 — Posted: 2021-01-21
Evidence of ongoing recombination in SARS-CoV-2 through genealogical reconstruction
Ignatieva, A., Hein, J., Jenkins, P. A.
10.1101/2021.01.21.427579 — Posted: 2021-01-21
Evaluating the Long-Term Efficacy of COVID-19 Vaccines
Lin, D., Zeng, D., Gilbert, P.
10.1101/2021.01.13.21249779 — Posted: 2021-01-21
Association between COVID-19 Outcomes and Mask Mandates, Adherence, and Attitudes
Adjodah, D., Dinakar, K., Chinazzi, M., Fraiberger, S. P., Pentland, A., Bates, S., Staller, K., Vespignani, A., Bhatt, D. L.
10.1101/2021.01.19.21250132 — Posted: 2021-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).